ARTICLE | Clinical News
Vestar Inc. regulatory update
June 21, 1993 7:00 AM UTC
Vestar Inc. (VSTR) Vestar Inc. (VSTR) said that AmBisome, its intravenous liposomal formulation of amphotericin B, received marketing approval in Greece as a treatment for systemic fungal infections...